Effects of an elemental diet to reduce adverse events in patients with esophageal cancer receiving docetaxel/cisplatin/5-fluorouracil: a phase III randomized controlled trial—EPOC 2 (JFMC49-1601-C5)

Y. Tanaka, H. Takeuchi, Y. Nakashima, H. Nagano, T. Ueno, K. Tomizuka, S. Morita, Y. Emi, Y. Hamai, J. Hihara, H. Saeki, E. Oki, C. Kunisaki, E. Otsuji, H. Baba, H. Matsubara, Y. Maehara, Y. Kitagawa, K. Yoshida

研究成果: Article査読

2 被引用数 (Scopus)

フィンガープリント

「Effects of an elemental diet to reduce adverse events in patients with esophageal cancer receiving docetaxel/cisplatin/5-fluorouracil: a phase III randomized controlled trial—EPOC 2 (JFMC49-1601-C5)」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

Medicine & Life Sciences